Stocks · Health care · Services-Medical Laboratories

GRAIL, Inc.

GRAL Clue Score54
United States Fiscal year ends December CIK 0001699031 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
10,000
$110.00
$1.10M
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
2,100
$100.68
$211.43K
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
421
$99.85
$42.04K
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
1,400
$97.84
$136.98K
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
6,200
$96.43
$597.87K
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
37,752
$94.98
$3.59M
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
1,454
$93.61
$136.10K
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
2,125
$92.32
$196.17K

What was left out

Form 4 filings counted 100
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 8
Sales at will 49
Transactions with no price 0
Shares from compensation/vesting 28,964,338
History held since 24 Jun 2024